Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HALO
#827
Halozyme Therapeutics, Inc. - Common Stock
105.3
5
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.47%
Monthly Change
+28.88%
6 month change
+54.19%
Year Change
+57.71%
Previous Close
106.9
2
Open
105.3
5
Low
105.3
5
High
105.3
5
Volume
139
Markets
US Stock Market
Healthcare
Biotechnology
HALO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
135.28 M
137.7 M
135.37 M
126.82 M
123.15 M
118.02 M
113.5 M
Valuation ratios
Enterprise value
6.03 B
6.3 B
8.73 B
6.12 B
7.28 B
9.95 B
14.06 B
Price to earnings ratio
46.93
14.68
38.28
17.8
13.94
26.29
31.12
Price to sales ratio
22.58
13.31
11.74
6.05
6.09
5.97
7.84
Price to cash flow ratio
108.95
19.71
32.28
12.91
12.92
12.8
15.93
Price to book ratio
40
29.97
45.65
59.87
17.01
170.83
14.22
Enterprise value to EBITDA ratio
40.85
22.57
31.88
17.56
12.96
20.71
22.98
Profitability ratios
Return on assets %
0.22
0.36
0.11
0.16
0.22
0.13
0.09
Return on equity %
0.85
2.04
1.19
3.36
1.22
6.49
1.6
Return on invested capital %
142.63
109.99
102.11
76.15
106.21
57.5
41.38
Gross margin %
83.79
81.64
78.9
76.8
84.3
83.62
83.54
Operating margin %
53.91
62.24
40.53
40.71
54.32
33.58
59.8
EBITDA margin %
55.14
62.91
41.51
42.04
55.33
34.4
60.74
Net margin %
48.24
90.84
30.62
33.96
43.74
22.69
47.8
Liquidity ratios
Quick ratio
1.17
7.45
4.88
5.5
6.78
3.66
2.31
Current ratio
1.32
7.91
5.65
6.64
7.8
4.66
2.71
Inventory turnover
0.96
1.42
1.81
1.69
1.18
1.3
0.54
Asset turnover
0.47
0.53
0.45
0.46
0.53
0.55
0.18
Solvency ratios
Debt to assets ratio
0
0.71
0.81
0.86
0.73
0.85
0.83
Debt to equity ratio
0
4
8.79
17.89
4.14
43.89
14.95
Long term debt to total assets ratio
0
0.71
0.81
0.86
0.73
0.85
—
Long term debt to total equity ratio
0
4
8.79
17.89
4.14
43.89
—
Per share metrics
Operating cash flow per share
0.39
2.04
1.71
2.9
3.7
5.26
6.68
EBIT per share
1.02
1.88
1.9
2.52
4.26
3.79
4.91
EBITDA per share
1.04
1.9
1.95
2.6
4.34
3.88
5.03
Total debt per share
2.81
5.97
10.71
11.17
11.63
17.29
17.71
Cash per share
2.6
5.05
2.58
0.88
0.9
1.08
1.35
Net current asset value per share
3.92
6.31
5.26
5.56
8.39
6.66
7.7
Tangible book value per share
1.07
1.34
1.21
0.62
2.81
-12.21
-11.22
Working capital per share
0.94
5.51
4.33
4.72
7.31
5.23
4.86
Book value per share
1.07
1.34
1.21
0.62
2.81
0.39
1.18
News
Tight Action In HALO Stock Sets Up Heavenly Gains
Are You Looking for a Top Momentum Pick? Why Halozyme Therapeutics (HALO) is a Great Choice
Zacks.com featured highlights Herbalife, Honda Motor, Marathon, Halozyme and Genworth
5 Value Stocks to Buy Right Now as Inflation Remains Sticky
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
5 Biotech Stocks Worth Adding to Your Portfolio Now
Analysts See Drastic Change For This Particular Part Of Healthcare
NeoGenomics, Inc. (NEO) Hits Fresh High: Is There Still Room to Run?
HALO Stock Rises 36% in a Month: Here's What You Should Know
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why